Overcoming a development challenge: Characterising aggregated material in formulated product
Dr Michael Caves, India Business Development Manager, Malvern Instruments and Dr Namrata Jain, Product Technical Specialist —…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
‘Spiolto will allow patients to lead a more normal life’
Boehringer Ingelheim has recently published a clinical trial data on Spiolto Respimat at ERS Congress in Amsterdam. Prof Dave…
Abbott dissolving stent succeeds in pivotal US trial: Study
The bioabsorbable Absorb stent succeeded in demonstrating non-inferiority to Xience up to one year after implantation in the…
A Wake Up Call On NCDs
Changing lifestyles have led to an alarming growth of NCDs in India. Realising the need to tackle this menace and the burden it…
NovaLead Pharma completes global phase I /II clinical trial for Galnobax
Galnobax, a topical gel, will help in the treatment of diabetic foot ulcer
NovaLead Pharma announced a potential breakthrough…
Swati Spentose: Small Is The Next Big?
After successfully launching the world’s first ever generic Pentosan Polysulfate Sodium (PPS) for interstitial cystitis, and now…
Healthcare initiative Project ĀSMĀN launched
The Bill & Melinda Gates Foundation, MSD in India, Reliance Foundation, Tata Trusts and USAID join hands to form…
‘We do not envisage launch of Fertin’s own brand’
Fertin India, a fully-owned subsidiary of Denmark-based Fertin Pharma, is soon going to start operations at its Goa plant. S Ravi…
Govt restricts pharma cos from giving gifts to docs
DoP’s Uniform Code of Pharmaceuticals Marketing Practices (UCPMP) prohibits companies from supplying drugs as samples
Lupin in agreement with BI
Lupin to market Linagliptin for Boehringer Ingelheim under the brand name Ondero and Ondero Met in India